OraSure Technologies reported $26.76M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.88B 43M Jun/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Bio Techne USD 299.71M 21.49M Sep/2026
Bio-Rad Laboratories USD 656.4M 5.4M Sep/2026
Bruker USD 874M 35.5M Sep/2026
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 982.7M 17.3M Sep/2026
Danaher USD 6.55B 254M Sep/2026
Dentsply International USD 836M 62M Sep/2026
Dexcom USD 1.34B 30M Sep/2026
Illumina USD 1.17B 10M Sep/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Mettler Toledo International USD 1.09B 60M Sep/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 618.9M 12M Sep/2026
Repligen USD 209M 5M Sep/2026
Revvity USD 729M 680K Sep/2026
STAAR Surgical USD 83.4M 10.1M Sep/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Trinity Biotech USD 10.85M 226K Mar/2026
Waters USD 1.77B 130M Sep/2026